Vitamin D and Innate and Adaptive Immunity

Vitamins and Hormones

Volumn 86, Issue , 2011, Pages 23-62

  Hewison, Martin ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Antibacterial; Autoimmune disease; Cathelicidin; CYP27b1; Infection; Macrophage; Regulatory T cells; Toll like receptor; Vitamin D; Vitamin D receptor

Indexed keywords

VITAMIN D;

ADAPTIVE IMMUNITY; ANIMAL; BOOK; HUMAN; IMMUNOLOGY; INNATE IMMUNITY; PATHOPHYSIOLOGY; PHYSIOLOGY; VITAMIN D DEFICIENCY;

ADAPTIVE IMMUNITY; ANIMALS; HUMANS; IMMUNITY, INNATE; VITAMIN D; VITAMIN D DEFICIENCY;

EID: 79952810814     PISSN: 00836729     EISSN: None     Source Type: Book Series    
DOI: 10.1016/B978-0-12-386960-9.00002-2     Document Type: Book

References (200)

1. Abbas A.K., Murphy K.M., Sher A. Functional diversity of helper T lymphocytes. Nature 1996, 383:787-793.
2. Abreu M.T., Kantorovich V., Vasiliauskas E.A., Gruntmanis U., Matuk R., Daigle K., Chen S., Zehnder D., Lin Y.C., Yang H., Hewison M., Adams J.S. Measurement of vitamin D levels in inflammatory bowel disease patients reveals a subset of Crohn@apos;s disease patients with elevated 1,25-dihydroxyvitamin D and low bone mineral density. Gut 2004, 53:1129-1136.
3. Adams J.S., Gacad M.A. Characterization of 1 alpha-hydroxylation of vitamin D3 sterols by cultured alveolar macrophages from patients with sarcoidosis. J. Exp. Med. 1985, 161:755-765.
4. Adams J.S., Sharma O.P., Gacad M.A., Singer F.R. Metabolism of 25-hydroxyvitamin D3 by cultured pulmonary alveolar macrophages in sarcoidosis. J. Clin. Invest. 1983, 72:1856-1860.
5. Adams J.S., Ren S., Liu P.T., Chun R.F., Lagishetty V., Gombart A.F., Borregaard N., Modlin R.L., Hewison M. Vitamin d-directed rheostatic regulation of monocyte antibacterial responses. J. Immunol. 2009, 182:4289-4295.
6. Adorini L., Penna G. Control of autoimmune diseases by the vitamin D endocrine system. Nat. Clin. Pract. Rheumatol. 2008, 4:404-412.
7. Aloia J.F., Li-Ng M. Correspondence. Epidemiol. Infect. 2007, 135:1095-1096.
8. Anderson K.V. Toll signaling pathways in the innate immune response. Curr. Opin. Immunol. 2000, 12:13-19.
9. + T cells in renal transplant recipients. Transplant. Proc. 2007, 39:951-953.
10. Ascherio A., Munger K.L., Simon K.C. Vitamin D and multiple sclerosis. Lancet Neurol. 2010, 9:599-612.
11. Babbe H., Roers A., Waisman A., Lassmann H., Goebels N., Hohlfeld R., Friese M., Schroder R., Deckert M., Schmidt S., Ravid R., Rajewsky K. Clonal expansions of CD8(+) T cells dominate the T cell infiltrate in active multiple sclerosis lesions as shown by micromanipulation and single cell polymerase chain reaction. J. Exp. Med. 2000, 192:393-404.
12. Bailey R., Cooper J.D., Zeitels L., Smyth D.J., Yang J.H., Walker N.M., Hypponen E., Dunger D.B., Ramos-Lopez E., Badenhoop K., Nejentsev S., Todd J.A. Association of the vitamin D metabolism gene CYP27B1 with type 1 diabetes. Diabetes 2007, 56:2616-2621.
13. Barrat F.J., Cua D.J., Boonstra A., Richards D.F., Crain C., Savelkoul H.F., de Waal-Malefyt R., Coffman R.L., Hawrylowicz C.M., O Garra A. In vitro generation of interleukin 10-producing regulatory CD4(+) T cells is induced by immunosuppressive drugs and inhibited by T helper type 1 (Th1)- and Th2-inducing cytokines. J. Exp. Med. 2002, 195:603-616.
14. Becklund B.R., Severson K.S., Vang S.V., DeLuca H.F. UV radiation suppresses experimental autoimmune encephalomyelitis independent of vitamin D production. Proc. Natl. Acad. Sci. USA 2010, 107:6418-6423.
15. Beretich B., Beretich T. Explaining multiple sclerosis prevalence by ultraviolet exposure: A geospatial analysis. Mult. Scler. 2009, 15:891-898.
16. Bergman P., Walter-Jallow L., Broliden K., Agerberth B., Soderlund J. The antimicrobial peptide LL-37 inhibits HIV-1 replication. Curr. HIV Res. 2007, 5:410-415.
17. Bhalla A.K., Amento E.P., Clemens T.L., Holick M.F., Krane S.M. Specific high-affinity receptors for 1,25-dihydroxyvitamin D3 in human peripheral blood mononuclear cells: Presence in monocytes and induction in T lymphocytes following activation. J. Clin. Endocrinol. Metab. 1983, 57:1308-1310.
18. Bhalla A.K., Amento E.P., Serog B., Glimcher L.H. 1,25-Dihydroxyvitamin D3 inhibits antigen-induced T cell activation. J. Immunol. 1984, 133:1748-1754.
19. + DC, with a plasmacytoid phenotype, induce differentiation and support function of T cells with regulatory properties. Immunology 2003, 108:481-492.
20. Bodnar L.M., Simhan H.N., Powers R.W., Frank M.P., Cooperstein E., Roberts J.M. High prevalence of vitamin D insufficiency in black and white pregnant women residing in the northern United States and their neonates. J. Nutr. 2007, 137:447-452.
21. Bodnar L.M., Krohn M.A., Simhan H.N. Maternal vitamin D deficiency is associated with bacterial vaginosis in the first trimester of pregnancy. J. Nutr. 2009, 139:1157-1161.
22. Boonstra A., Barrat F.J., Crain C., Heath V.L., Savelkoul H.F., O Garra A. 1alpha, 25-Dihydroxyvitamin d3 has a direct effect on naive CD4(+) T cells to enhance the development of Th2 cells. J. Immunol. 2001, 167:4974-4980.
23. Brennan A., Katz D.R., Nunn J.D., Barker S., Hewison M., Fraher L.J., O Riordan J.L. Dendritic cells from human tissues express receptors for the immunoregulatory vitamin D3 metabolite, dihydroxycholecalciferol. Immunology 1987, 61:457-461.
24. Brightbill H.D., Modlin R.L. Toll-like receptors: Molecular mechanisms of the mammalian immune response. Immunology 2000, 101:1-10.
25. Brightbill H.D., Libraty D.H., Krutzik S.R., Yang R.B., Belisle J.T., Bleharski J.R., Maitland M., Norgard M.V., Plevy S.E., Smale S.T., Brennan P.J., Bloom B.R., et al. Host defense mechanisms triggered by microbial lipoproteins through toll-like receptors. Science 1999, 285:732-736.
26. Bunce C.M., Brown G., Hewison M. Vitamin D and haematopoiesis. Trends Endocrinol. Metab. 1997, 8:245-251.
27. Cannell J.J., Vieth R., Umhau J.C., Holick M.F., Grant W.B., Madronich S., Garland C.F., Giovannucci E. Epidemic influenza and vitamin D. Epidemiol. Infect. 2006, 134:1129-1140.
28. Chan J., Xing Y., Magliozzo R.S., Bloom B.R. Killing of virulent Mycobacterium tuberculosis by reactive nitrogen intermediates produced by activated murine macrophages. J. Exp. Med. 1992, 175:1111-1122.
29. Chapuy M.C., Preziosi P., Maamer M., Arnaud S., Galan P., Hercberg S., Meunier P.J. Prevalence of vitamin D insufficiency in an adult normal population. Osteoporos. Int. 1997, 7:439-443.
30. Chen S., Sims G.P., Chen X.X., Gu Y.Y., Chen S., Lipsky P.E. Modulatory effects of 1,25-dihydroxyvitamin d3 on human B cell differentiation. J. Immunol. 2007, 179:1634-1647.
31. Cheroutre H., Lambolez F. Doubting the TCR coreceptor function of CD8alphaalpha. Immunity 2008, 28:149-159.
32. Chishimba L., Thickett D.R., Stockley R.A., Wood A.M. The vitamin D axis in the lung: A key role for vitamin D-binding protein. Thorax 2010, 65:456-462.
33. Chun R.F., Lauridsen A., Suon L., Zella L.A., Pike J.W., Modlin R.L., Martineau A.R., Wilkinson R.J., Adams J.S., Hewison M. Vitamin D binding protein directs monocyte responses to 25-hydroxy- and 1,25-dihydroxyvitamin D. J. Clin. Endocrinol. Metab. 2010, 95:3368-3376.
34. Cuthbert A.P., Fisher S.A., Mirza M.M., King K., Hampe J., Croucher P.J., Mascheretti S., Sanderson J., Forbes A., Mansfield J., Schreiber S., Lewis C.M., et al. The contribution of NOD2 gene mutations to the risk and site of disease in inflammatory bowel disease. Gastroenterology 2002, 122:867-874.
35. Cyster J.G. Chemokines and the homing of dendritic cells to the T cell areas of lymphoid organs. J. Exp. Med. 1999, 189:447-450.
36. Dam T.N., Moller B., Hindkjaer J., Kragballe K. The vitamin D3 analog calcipotriol suppresses the number and antigen-presenting function of Langerhans cells in normal human skin. J. Investig. Dermatol. Symp. Proc. 1996, 1:72-77.
37. Davies M., Mawer E.B., Krawitt E.L. Comparative absorption of vitamin D3 and 25-hydroxyvitamin D3 in intestinal disease. Gut 1980, 21:287-292.
38. Delgado M., Singh S., De Haro S., Master S., Ponpuak M., Dinkins C., Ornatowski W., Vergne I., Deretic V. Autophagy and pattern recognition receptors in innate immunity. Immunol. Rev. 2009, 227:189-202.
39. Deretic V., Levine B. Autophagy, immunity, and microbial adaptations. Cell Host Microbe 2009, 5:527-549.
40. Dhodapkar M.V., Steinman R.M., Krasovsky J., Munz C., Bhardwaj N. Antigen-specific inhibition of effector T cell function in humans after injection of immature dendritic cells. J. Exp. Med. 2001, 193:233-238.
41. Dong X., Craig T., Xing N., Bachman L.A., Paya C.V., Weih F., McKean D.J., Kumar R., Griffin M.D. Direct transcriptional regulation of RelB by 1alpha, 25-dihydroxyvitamin D3 and its analogs: Physiologic and therapeutic implications for dendritic cell function. J. Biol. Chem. 2003, 278:49378-49385.
42. Dong X., Lutz W., Schroeder T.M., Bachman L.A., Westendorf J.J., Kumar R., Griffin M.D. Regulation of relB in dendritic cells by means of modulated association of vitamin D receptor and histone deacetylase 3 with the promoter. Proc. Natl. Acad. Sci. USA 2005, 102:16007-16012.
43. Ehrchen J., Helming L., Varga G., Pasche B., Loser K., Gunzer M., Sunderkotter C., Sorg C., Roth J., Lengeling A. Vitamin D receptor signaling contributes to susceptibility to infection with Leishmania major. FASEB J. 2007, 21:3208-3218.
44. Evans K.N., Bulmer J.N., Kilby M.D., Hewison M. Vitamin D and placental-decidual function. J. Soc. Gynecol. Investig. 2004, 11:263-271.
45. Evans K.N., Nguyen L., Chan J., Innes B.A., Bulmer J.N., Kilby M.D., Hewison M. Effects of 25-hydroxyvitamin D3 and 1,25-dihydroxyvitamin D3 on cytokine production by human decidual cells. Biol. Reprod. 2006, 75:816-822.
46. Fritsche J., Mondal K., Ehrnsperger A., Andreesen R., Kreutz M. Regulation of 25-hydroxyvitamin D3-1 alpha-hydroxylase and production of 1 alpha, 25-dihydroxyvitamin D3 by human dendritic cells. Blood 2003, 102:3314-3316.
47. Froicu M., Cantorna M.T. Vitamin D and the vitamin D receptor are critical for control of the innate immune response to colonic injury. BMC Immunol. 2007, 8:5.
48. Froicu M., Weaver V., Wynn T.A., McDowell M.A., Welsh J.E., Cantorna M.T. A crucial role for the vitamin D receptor in experimental inflammatory bowel diseases. Mol. Endocrinol. 2003, 17:2386-2392.
49. Fu G.K., Lin D., Zhang M.Y., Bikle D.D., Shackleton C.H., Miller W.L., Portale A.A. Cloning of human 25-hydroxyvitamin D-1 alpha-hydroxylase and mutations causing vitamin D-dependent rickets type 1. Mol. Endocrinol. 1997, 11:1961-1970.
50. Fuss M., Pepersack T., Gillet C., Karmali R., Corvilain J. Calcium and vitamin D metabolism in granulomatous diseases. Clin. Rheumatol. 1992, 11:28-36.
51. Garcion E., Nataf S., Berod A., Darcy F., Brachet P. 1,25-Dihydroxyvitamin D3 inhibits the expression of inducible nitric oxide synthase in rat central nervous system during experimental allergic encephalomyelitis. Brain Res. Mol. Brain Res. 1997, 45:255-267.
52. Ghoreishi M., Bach P., Obst J., Komba M., Fleet J.C., Dutz J.P. Expansion of antigen-specific regulatory T cells with the topical vitamin d analog calcipotriol. J. Immunol. 2009, 182:6071-6078.
53. Ginde A.A., Liu M.C., Camargo C.A. Demographic differences and trends of vitamin D insufficiency in the US population, 1988-2004. Arch. Intern. Med. 2009, 169:626-632.
54. Giulietti A., Gysemans C., Stoffels K., van Etten E., Decallonne B., Overbergh L., Bouillon R., Mathieu C. Vitamin D deficiency in early life accelerates Type 1 diabetes in non-obese diabetic mice. Diabetologia 2004, 47:451-462.
55. Gombart A.F., Borregaard N., Koeffler H.P. Human cathelicidin antimicrobial peptide (CAMP) gene is a direct target of the vitamin D receptor and is strongly up-regulated in myeloid cells by 1,25-dihydroxyvitamin D3. FASEB J. 2005, 19:1067-1077.
56. Gombart A.F., Bhan I., Borregaard N., Tamez H., Camargo C.A., Koeffler H.P., Thadhani R. Low plasma level of cathelicidin antimicrobial peptide (hCAP18) predicts increased infectious disease mortality in patients undergoing hemodialysis. Clin. Infect. Dis. 2009, 48:418-424.
57. Gombart A.F., Saito T., Koeffler H.P. Exaptation of an ancient Alu short interspersed element provides a highly conserved vitamin D-mediated innate immune response in humans and primates. BMC Genomics 2009, 10:321.
58. + cells in the draining lymph nodes. J. Immunol. 2007, 179:6273-6283.
59. Griffin M.D., Lutz W.H., Phan V.A., Bachman L.A., McKean D.J., Kumar R. Potent inhibition of dendritic cell differentiation and maturation by vitamin D analogs. Biochem. Biophys. Res. Commun. 2000, 270:701-708.
60. Griffin M.D., Lutz W., Phan V.A., Bachman L.A., McKean D.J., Kumar R. Dendritic cell modulation by 1alpha, 25 dihydroxyvitamin D3 and its analogs: A vitamin D receptor-dependent pathway that promotes a persistent state of immaturity in vitro and in vivo. Proc. Natl. Acad. Sci. USA 2001, 98:6800-6805.
61. Gutierrez M.G., Master S.S., Singh S.B., Taylor G.A., Colombo M.I., Deretic V. Autophagy is a defense mechanism inhibiting BCG and Mycobacterium tuberculosis survival in infected macrophages. Cell 2004, 119:753-766.
62. Hansdottir S., Monick M.M., Hinde S.L., Lovan N., Look D.C., Hunninghake G.W. Respiratory epithelial cells convert inactive vitamin D to its active form: Potential effects on host defense. J. Immunol. 2008, 181:7090-7099.
63. Harris S.S. Vitamin D in type 1 diabetes prevention. J. Nutr. 2005, 135:323-325.
64. Hayes M.E., Rai A., Cooper R.G., Bayley D., Freemont A.J., Mawer E.B. Inhibition by prostaglandin E1 and E2 of 1,25-dihydroxyvitamin D3 synthesis by synovial fluid macrophages from arthritic joints. Ann. Rheum. Dis. 1992, 51:632-637.
65. Heine G., Niesner U., Chang H.D., Steinmeyer A., Zugel U., Zuberbier T., Radbruch A., Worm M. 1,25-dihydroxyvitamin D(3) promotes IL-10 production in human B cells. Eur. J. Immunol. 2008, 38:2210-2218.
66. Hewison M. Vitamin D and the intracrinology of innate immunity. Mol. Cell. Endocrinol. 2010, 321:103-111.
67. Hewison M., Barker S., Brennan A., Nathan J., Katz D.R., O Riordan J.L. Autocrine regulation of 1,25-dihydroxycholecalciferol metabolism in myelomonocytic cells. Immunology 1989, 68:247-252.
68. Hewison M., Brennan A., Singh-Ranger R., Walters J.C., Katz D.R., O Riordan J.L. The comparative role of 1,25-dihydroxycholecalciferol and phorbol esters in the differentiation of the U937 cell line. Immunology 1992, 77:304-311.
69. Hewison M., Freeman L., Hughes S.V., Evans K.N., Bland R., Eliopoulos A.G., Kilby M.D., Moss P.A., Chakraverty R. Differential regulation of vitamin D receptor and its ligand in human monocyte-derived dendritic cells. J. Immunol. 2003, 170:5382-5390.
70. Hewison M., Zehnder D., Chakraverty R., Adams J.S. Vitamin D and barrier function: A novel role for extra-renal 1 alpha-hydroxylase. Mol. Cell. Endocrinol. 2004, 215:31-38.
71. Hewison M., Burke F., Evans K.N., Lammas D.A., Sansom D.M., Liu P., Modlin R.L., Adams J.S. Extra-renal 25-hydroxyvitamin D3-1alpha-hydroxylase in human health and disease. J. Steroid Biochem. Mol. Biol. 2007, 103:316-321.
72. Holick M.F. Vitamin D deficiency. N. Engl. J. Med. 2007, 357:266-281.
73. Hooper L.V., Stappenbeck T.S., Hong C.V., Gordon J.I. Angiogenins: A new class of microbicidal proteins involved in innate immunity. Nat. Immunol. 2003, 4:269-273.
74. Hugot J.P., Chamaillard M., Zouali H., Lesage S., Cezard J.P., Belaiche J., Almer S., Tysk C., O Morain C.A., Gassull M., Binder V., Finkel Y., et al. Association of NOD2 leucine-rich repeat variants with susceptibility to Crohns disease. Nature 2001, 411:599-603.
75. Iho S., Takahashi T., Kura F., Sugiyama H., Hoshino T. The effect of 1,25-dihydroxyvitamin D3 on in vitro immunoglobulin production in human B cells. J. Immunol. 1986, 136:4427-4431.
76. Janeway C.A., Medzhitov R. Innate immune recognition. Annu. Rev. Immunol. 2002, 20:197-216.
77. Jeffery L.E., Burke F., Mura M., Zheng Y., Qureshi O.S., Hewison M., Walker L.S., Lammas D.A., Raza K., Sansom D.M. 1,25-Dihydroxyvitamin D(3) and IL-2 combine to inhibit T cell production of inflammatory cytokines and promote development of regulatory T cells expressing CTLA-4 and FoxP3. J. Immunol. 2009, 183:5458-5467.
78. Jeng L., Yamshchikov A.V., Judd S.E., Blumberg H.M., Martin G.S., Ziegler T.R., Tangpricha V. Alterations in vitamin D status and anti-microbial peptide levels in patients in the intensive care unit with sepsis. J. Transl. Med. 2009, 7:28.
79. Jonuleit H., Schmitt E., Schuler G., Knop J., Enk A.H. Induction of interleukin 10-producing, nonproliferating CD4(+) T cells with regulatory properties by repetitive stimulation with allogeneic immature human dendritic cells. J. Exp. Med. 2000, 192:1213-1222.
80. Josien R., Wong B.R., Li H.L., Steinman R.M., Choi Y. TRANCE, a TNF family member, is differentially expressed on T cell subsets and induces cytokine production in dendritic cells. J. Immunol. 1999, 162:2562-2568.
81. Jurutka P.W., Bartik L., Whitfield G.K., Mathern D.R., Barthel T.K., Gurevich M., Hsieh J.C., Kaczmarska M., Haussler C.A., Haussler M.R. Vitamin D receptor: Key roles in bone mineral pathophysiology, molecular mechanism of action, and novel nutritional ligands. J. Bone Miner. Res. 2007, 22(Suppl. 2):V2-V10.
82. Kallas M., Green F., Hewison M., White C., Kline G. Rare causes of calcitriol-mediated hypercalcemia: A case report and literature review. J. Clin. Endocrinol. Metab. 2010, 95:3111-3117.
83. Kamboh M.I., Ferrell R.E. Ethnic variation in vitamin D-binding protein (GC): A review of isoelectric focusing studies in human populations. Hum. Genet. 1986, 72:281-293.
84. Karmali R., Hewison M., Rayment N., Farrow S.M., Brennan A., Katz D.R., O Riordan J.L. 1,25(OH)2D3 regulates c-myc mRNA levels in tonsillar T lymphocytes. Immunology 1991, 74:589-593.
85. Klionsky D.J., Emr S.D. Autophagy as a regulated pathway of cellular degradation. Science 2000, 290:1717-1721.
86. Koeffler H.P., Reichel H., Bishop J.E., Norman A.W. gamma-Interferon stimulates production of 1,25-dihydroxyvitamin D3 by normal human macrophages. Biochem. Biophys. Res. Commun. 1985, 127:596-603.
87. Kohchi C., Inagawa H., Nishizawa T., Soma G. ROS and innate immunity. Anticancer Res. 2009, 29:817-821.
88. Koizumi T., Nakao Y., Matsui T., Nakagawa T., Katakami Y., Fujita T. Effect of 1,25-dihydroxyvitamin D3 on cytokine-induced thymocyte proliferation. Cell. Immunol. 1985, 96:455-461.
89. Kong J., Zhang Z., Musch M.W., Ning G., Sun J., Hart J., Bissonnette M., Li Y.C. Novel role of the vitamin D receptor in maintaining the integrity of the intestinal mucosal barrier. Am. J. Physiol. Gastrointest. Liver Physiol. 2008, 294:G208-G216.
90. Kreutz M., Andreesen R., Krause S.W., Szabo A., Ritz E., Reichel H. 1,25-dihydroxyvitamin D3 production and vitamin D3 receptor expression are developmentally regulated during differentiation of human monocytes into macrophages. Blood 1993, 82:1300-1307.
91. Krutzik S.R., Hewison M., Liu P.T., Robles J.A., Stenger S., Adams J.S., Modlin R.L. IL-15 links TLR2/1-induced macrophage differentiation to the vitamin D-dependent antimicrobial pathway. J. Immunol. 2008, 181:7115-7120.
92. Kumar H., Kawai T., Akira S. Pathogen recognition in the innate immune response. Biochem. J. 2009, 420:1-16.
93. Lagishetty V., Misharin A.V., Liu N.Q., Lisse T.S., Chun R.F., Ouyang Y., McLachlan S.M., Adams J.S., Hewison M. Vitamin D deficiency in mice impairs colonic antibacterial activity and predisposes to colitis. Endocrinology 2010, 151:2423-2432.
94. Leichtmann G.A., Bengoa J.M., Bolt M.J., Sitrin M.D. Intestinal absorption of cholecalciferol and 25-hydroxycholecalciferol in patients with both Crohn@apos;s disease and intestinal resection. Am. J. Clin. Nutr. 1991, 54:548-552.
95. Lemire J.M., Adams J.S., Kermani-Arab V., Bakke A.C., Sakai R., Jordan S.C. 1,25-Dihydroxyvitamin D3 suppresses human T helper/inducer lymphocyte activity in vitro. J. Immunol. 1985, 134:3032-3035.
96. Lemire J.M., Archer D.C., Beck L., Spiegelberg H.L. Immunosuppressive actions of 1,25-dihydroxyvitamin D3: Preferential inhibition of Th1 functions. J. Nutr. 1995, 125:1704S-1708S.
97. Littorin B., Blom P., Scholin A., Arnqvist H.J., Blohme G., Bolinder J., Ekbom-Schnell A., Eriksson J.W., Gudbjornsdottir S., Nystrom L., Ostman J., Sundkvist G. Lower levels of plasma 25-hydroxyvitamin D among young adults at diagnosis of autoimmune type 1 diabetes compared with control subjects: Results from the nationwide Diabetes Incidence Study in Sweden (DISS). Diabetologia 2006, 49:2847-2852.
98. Liu Y.J. IPC: Professional type 1 interferon-producing cells and plasmacytoid dendritic cell precursors. Annu. Rev. Immunol. 2005, 23:275-306.
99. Liu P.T., Stenger S., Li H., Wenzel L., Tan B.H., Krutzik S.R., Ochoa M.T., Schauber J., Wu K., Meinken C., Kamen D.L., Wagner M., et al. Toll-like receptor triggering of a vitamin D-mediated human antimicrobial response. Science 2006, 311:1770-1773.
100. Liu P.T., Stenger S., Tang D.H., Modlin R.L. Cutting edge: Vitamin D-mediated human antimicrobial activity against mycobacterium tuberculosis is dependent on the induction of cathelicidin. J. Immunol. 2007, 179:2060-2063.
101. Liu N., Nguyen L., Chun R.F., Lagishetty V., Ren S., Wu S., Hollis B., Deluca H.F., Adams J.S., Hewison M. Altered endocrine and autocrine metabolism of vitamin d in a mouse model of gastrointestinal inflammation. Endocrinology 2008, 149:4799-4808.
102. Liu N., Kaplan A.T., Low J., Nguyen L., Liu G.Y., Equils O., Hewison M. Vitamin D induces innate antibacterial responses in human trophoblasts via an intracrine pathway. Biol. Reprod. 2009, 80:398-406.
103. Liu P.T., Schenk M., Walker V.P., Dempsey P.W., Kanchanapoomi M., Wheelwright M., Vazirnia A., Zhang X., Steinmeyer A., Zugel U., Hollis B.W., Cheng G., et al. Convergence of IL-1beta and VDR activation pathways in human TLR2/1-induced antimicrobial responses. PLoS ONE 2009, 4:e5810.
104. Lo C.W., Paris P.W., Clemens T.L., Nolan J., Holick M.F. Vitamin D absorption in healthy subjects and in patients with intestinal malabsorption syndromes. Am. J. Clin. Nutr. 1985, 42:644-649.
105. Malloy P.J., Pike J.W., Feldman D. The vitamin D receptor and the syndrome of hereditary 1,25-dihydroxyvitamin D-resistant rickets. Endocr. Rev. 1999, 20:156-188.
106. Mamutse G., Woolmore J., Pye E., Partridge J., Boggild M., Young C., Fryer A., Hoban P.R., Rukin N., Alldersea J., Strange R.C., Hawkins C.P. Vitamin D receptor gene polymorphism is associated with reduced disability in multiple sclerosis. Mult. Scler. 2008, 14:1280-1283.
107. Martineau A.R., Honecker F.U., Wilkinson R.J., Griffiths C.J. Vitamin D in the treatment of pulmonary tuberculosis. J. Steroid Biochem. Mol. Biol. 2007, 103:793-798.
108. Martineau A.R., Wilkinson R.J., Wilkinson K.A., Newton S.M., Kampmann B., Hall B.M., Packe G.E., Davidson R.N., Eldridge S.M., Maunsell Z.J., Rainbow S.J., Berry J.L., et al. A single dose of vitamin d enhances immunity to mycobacteria. Am. J. Respir. Crit. Care Med. 2007, 176:208-213.
109. Mathieu C., Gysemans C., Giulietti A., Bouillon R. Vitamin D and diabetes. Diabetologia 2005, 48:1247-1257.
110. Mawer E.B., Hayes M.E., Still P.E., Davies M., Lumb G.A., Palit J., Holt P.J. Evidence for nonrenal synthesis of 1,25-dihydroxyvitamin D in patients with inflammatory arthritis. J. Bone Miner. Res. 1991, 6:733-739.
111. Medzhitov R., Janeway C. The toll receptor family and microbial recognition. Trends Microbiol. 2000, 8:452-456.
112. Meehan T.F., DeLuca H.F. CD8(+) T cells are not necessary for 1 alpha,25-dihydroxyvitamin D(3) to suppress experimental autoimmune encephalomyelitis in mice. Proc. Natl. Acad. Sci. USA 2002, 99:5557-5560.
113. Modlin R.L., Brightbill H.D., Godowski P.J. The toll of innate immunity on microbial pathogens. N. Engl. J. Med. 1999, 340:1834-1835.
114. Moller K.I., Kongshoj B., Philipsen P.A., Thomsen V.O., Wulf H.C. How Finsen@apos;s light cured lupus vulgaris. Photodermatol. Photoimmunol. Photomed. 2005, 21:118-124.
115. Nashold F.E., Spach K.M., Spanier J.A., Hayes C.E. Estrogen controls vitamin D3-mediated resistance to experimental autoimmune encephalomyelitis by controlling vitamin D3 metabolism and receptor expression. J. Immunol. 2009, 183:3672-3681.
116. Nguyen M., dAlesio A., Pascussi J.M., Kumar R., Griffin M.D., Dong X., Guillozo H., Rizk-Rabin M., Sinding C., Bougneres P., Jehan F., Garabedian M. Vitamin D-resistant rickets and type 1 diabetes in a child with compound heterozygous mutations of the vitamin D receptor (L263R and R391S): Dissociated responses of the CYP-24 and rel-B promoters to 1,25-dihydroxyvitamin D3. J. Bone Miner. Res. 2006, 21:886-894.
117. Nunn J.D., Katz D.R., Barker S., Fraher L.J., Hewison M., Hendy G.N., O Riordan J.L. Regulation of human tonsillar T-cell proliferation by the active metabolite of vitamin D3. Immunology 1986, 59:479-484.
118. Nursyam E.W., Amin Z., Rumende C.M. The effect of vitamin D as supplementary treatment in patients with moderately advanced pulmonary tuberculous lesion. Acta Med. Indones. 2006, 38:3-5.
119. Nykjaer A., Dragun D., Walther D., Vorum H., Jacobsen C., Herz J., Melsen F., Christensen E.I., Willnow T.E. An endocytic pathway essential for renal uptake and activation of the steroid 25-(OH) vitamin D3. Cell 1999, 96:507-515.
120. Nykjaer A., Fyfe J.C., Kozyraki R., Leheste J.R., Jacobsen C., Nielsen M.S., Verroust P.J., Aminoff M., de la Chapelle A., Moestrup S.K., Ray R., Gliemann J., et al. Cubilin dysfunction causes abnormal metabolism of the steroid hormone 25(OH) vitamin D(3). Proc. Natl. Acad. Sci. USA 2001, 98:13895-13900.
121. Ogura Y., Bonen D.K., Inohara N., Nicolae D.L., Chen F.F., Ramos R., Britton H., Moran T., Karaliuskas R., Duerr R.H., Achkar J.P., Brant S.R., et al. A frameshift mutation in NOD2 associated with susceptibility to Crohn@apos;s disease. Nature 2001, 411:603-606.
122. O Kelly J., Uskokovic M., Lemp N., Vadgama J., Koeffler H.P. Novel Gemini-vitamin D3 analog inhibits tumor cell growth and modulates the Akt/mTOR signaling pathway. J. Steroid Biochem. Mol. Biol. 2006, 100:107-116.
123. O Neil D.A., Porter E.M., Elewaut D., Anderson G.M., Eckmann L., Ganz T., Kagnoff M.F. Expression and regulation of the human beta-defensins hBD-1 and hBD-2 in intestinal epithelium. J. Immunol. 1999, 163:6718-6724.
124. Ong P.Y., Ohtake T., Brandt C., Strickland I., Boguniewicz M., Ganz T., Gallo R.L., Leung D.Y. Endogenous antimicrobial peptides and skin infections in atopic dermatitis. N. Engl. J. Med. 2002, 347:1151-1160.
125. Orton S.M., Morris A.P., Herrera B.M., Ramagopalan S.V., Lincoln M.R., Chao M.J., Vieth R., Sadovnick A.D., Ebers G.C. Evidence for genetic regulation of vitamin D status in twins with multiple sclerosis. Am. J. Clin. Nutr. 2008, 88:441-447.
126. Overbergh L., Decallonne B., Waer M., Rutgeerts O., Valckx D., Casteels K.M., Laureys J., Bouillon R., Mathieu C. 1alpha, 25-dihydroxyvitamin D3 induces an autoantigen-specific T-helper 1/T-helper 2 immune shift in NOD mice immunized with GAD65 (p524-543). Diabetes 2000, 49:1301-1307.
127. Packey C.D., Sartor R.B. Commensal bacteria, traditional and opportunistic pathogens, dysbiosis and bacterial killing in inflammatory bowel diseases. Curr. Opin. Infect. Dis. 2009, 22:292-301.
128. Pappa H.M., Gordon C.M., Saslowsky T.M., Zholudev A., Horr B., Shih M.C., Grand R.J. Vitamin D status in children and young adults with inflammatory bowel disease. Pediatrics 2006, 118:1950-1961.
129. Pappa H.M., Grand R.J., Gordon C.M. Report on the vitamin D status of adult and pediatric patients with inflammatory bowel disease and its significance for bone health and disease. Inflamm. Bowel Dis. 2006, 12:1162-1174.
130. Pedersen L.B., Nashold F.E., Spach K.M., Hayes C.E. 1,25-dihydroxyvitamin D3 reverses experimental autoimmune encephalomyelitis by inhibiting chemokine synthesis and monocyte trafficking. J. Neurosci. Res. 2007, 85:2480-2490.
131. Penna G., Adorini L. 1 Alpha, 25-dihydroxyvitamin D3 inhibits differentiation, maturation, activation, and survival of dendritic cells leading to impaired alloreactive T cell activation. J. Immunol. 2000, 164:2405-2411.
132. Penna G., Amuchastegui S., Cossetti C., Aquilano F., Mariani R., Sanvito F., Doglioni C., Adorini L. Treatment of experimental autoimmune prostatitis in nonobese diabetic mice by the vitamin D receptor agonist elocalcitol. J. Immunol. 2006, 177:8504-8511.
133. Penna G., Amuchastegui S., Giarratana N., Daniel K.C., Vulcano M., Sozzani S., Adorini L. 1,25-dihydroxyvitamin d3 selectively modulates tolerogenic properties in myeloid but not plasmacytoid dendritic cells. J. Immunol. 2007, 178:145-153.
134. Piemonti L., Monti P., Sironi M., Fraticelli P., Leone B.E., Dal Cin E., Allavena P., Di Carlo V. Vitamin D3 affects differentiation, maturation, and function of human monocyte-derived dendritic cells. J. Immunol. 2000, 164:4443-4451.
135. Pierrot-Deseilligny C., Souberbielle J.C. Is hypovitaminosis D one of the environmental risk factors for multiple sclerosis?. Brain 2010, 133:1869-1888.
136. Provvedini D.M., Manolagas S.C. 1 Alpha,25-dihydroxyvitamin D3 receptor distribution and effects in subpopulations of normal human T lymphocytes. J. Clin. Endocrinol. Metab. 1989, 68:774-779.
137. Provvedini D.M., Tsoukas C.D., Deftos L.J., Manolagas S.C. 1,25-dihydroxyvitamin D3 receptors in human leukocytes. Science 1983, 221:1181-1183.
138. Quarles L.D. Endocrine functions of bone in mineral metabolism regulation. J. Clin. Invest. 2008, 118:3820-3828.
139. Raghuwanshi A., Joshi S.S., Christakos S. Vitamin D and multiple sclerosis. J. Cell. Biochem. 2008, 105:338-343.
140. Ramos-Lopez E., Jansen T., Ivaskevicius V., Kahles H., Klepzig C., Oldenburg J., Badenhoop K. Protection from type 1 diabetes by vitamin D receptor haplotypes. Ann. NY Acad. Sci. 2006, 1079:327-334.
141. Ravid A., Koren R., Novogrodsky A., Liberman U.A. 1,25-Dihydroxyvitamin D3 inhibits selectively the mitogenic stimulation of mouse medullary thymocytes. Biochem. Biophys. Res. Commun. 1984, 123:163-169.
142. Reichel H., Koeffler H.P., Bishop J.E., Norman A.W. 25-Hydroxyvitamin D3 metabolism by lipopolysaccharide-stimulated normal human macrophages. J. Clin. Endocrinol. Metab. 1987, 64:1-9.
143. Ren S., Nguyen L., Wu S., Encinas C., Adams J.S., Hewison M. Alternative splicing of vitamin D-24-hydroxylase: A novel mechanism for the regulation of extrarenal 1,25-dihydroxyvitamin D synthesis. J. Biol. Chem. 2005, 280:20604-20611.
144. Rigby W.F., Noelle R.J., Krause K., Fanger M.W. The effects of 1,25-dihydroxyvitamin D3 on human T lymphocyte activation and proliferation: A cell cycle analysis. J. Immunol. 1985, 135:2279-2286.
145. Rigby W.F., Denome S., Fanger M.W. Regulation of lymphokine production and human T lymphocyte activation by 1,25-dihydroxyvitamin D3. Specific inhibition at the level of messenger RNA. J. Clin. Invest. 1987, 79:1659-1664.
146. Rigby W.F., Yirinec B., Oldershaw R.L., Fanger M.W. Comparison of the effects of 1,25-dihydroxyvitamin D3 on T lymphocyte subpopulations. Eur. J. Immunol. 1987, 17:563-566.
147. Rigby W.F., Hamilton B.J., Waugh M.G. 1,25-Dihydroxyvitamin D3 modulates the effects of interleukin 2 independent of IL-2 receptor binding. Cell. Immunol. 1990, 125:396-414.
148. Rockett K.A., Brookes R., Udalova I., Vidal V., Hill A.V., Kwiatkowski D. 1,25-Dihydroxyvitamin D3 induces nitric oxide synthase and suppresses growth of Mycobacterium tuberculosis in a human macrophage-like cell line. Infect. Immun. 1998, 66:5314-5321.
149. Romagnani S. Regulation of the T cell response. Clin. Exp. Allergy 2006, 36:1357-1366.
150. Rook G.A., Steele J., Fraher L., Barker S., Karmali R., O Riordan J., Stanford J. Vitamin D3, gamma interferon, and control of proliferation of Mycobacterium tuberculosis by human monocytes. Immunology 1986, 57:159-163.
151. Rowling M.J., Kemmis C.M., Taffany D.A., Welsh J. Megalin-mediated endocytosis of vitamin D binding protein correlates with 25-hydroxycholecalciferol actions in human mammary cells. J. Nutr. 2006, 136:2754-2759.
152. Royal W., Mia Y., Li H., Naunton K. Peripheral blood regulatory T cell measurements correlate with serum vitamin D levels in patients with multiple sclerosis. J. Neuroimmunol. 2009, 213:135-141.
153. Sakaki T., Kagawa N., Yamamoto K., Inouye K. Metabolism of vitamin D3 by cytochromes P450. Front. Biosci. 2005, 10:119-134.
154. Sanjuan M.A., Milasta S., Green D.R. Toll-like receptor signaling in the lysosomal pathways. Immunol. Rev. 2009, 227:203-220.
155. Schauber J., Gallo R.L. Expanding the roles of antimicrobial peptides in skin: Alarming and arming keratinocytes. J. Invest. Dermatol. 2007, 127:510-512.
156. Schauber J., Dorschner R.A., Coda A.B., Buchau A.S., Liu P.T., Kiken D., Helfrich Y.R., Kang S., Elalieh H.Z., Steinmeyer A., Zugel U., Bikle D.D., et al. Injury enhances TLR2 function and antimicrobial peptide expression through a vitamin D-dependent mechanism. J. Clin. Invest. 2007, 117:803-811.
157. Schoenborn J.R., Wilson C.B. Regulation of interferon-gamma during innate and adaptive immune responses. Adv. Immunol. 2007, 96:41-101.
158. Shimada T., Kakitani M., Yamazaki Y., Hasegawa H., Takeuchi Y., Fujita T., Fukumoto S., Tomizuka K., Yamashita T. Targeted ablation of Fgf23 demonstrates an essential physiological role of FGF23 in phosphate and vitamin D metabolism. J. Clin. Invest. 2004, 113:561-568.
159. Shin D.M., Yuk J.M., Lee H.M., Lee S.H., Son J.W., Harding C.V., Kim J.M., Modlin R.L., Jo E.K. Mycobacterial lipoprotein activates autophagy via TLR2/1/CD14 and a functional vitamin D receptor signaling. Cell. Microbiol. 2010, 12:1648-1665.
160. Shiozawa K., Shiozawa S., Shimizu S., Fujita T. 1 alpha, 25-dihydroxyvitamin D3 inhibits pokeweed mitogen-stimulated human B-cell activation: An analysis using serum-free culture conditions. Immunology 1985, 56:161-167.
161. Shirakawa A.K., Nagakubo D., Hieshima K., Nakayama T., Jin Z., Yoshie O. 1,25-dihydroxyvitamin D3 induces CCR10 expression in terminally differentiating human B cells. J. Immunol. 2008, 180:2786-2795.
162. Sigmundsdottir H., Pan J., Debes G.F., Alt C., Habtezion A., Soler D., Butcher E.C. DCs metabolize sunlight-induced vitamin D3 to 'program' T cell attraction to the epidermal chemokine CCL27. Nat. Immunol. 2007, 8:285-293.
163. Simon K.C., Munger K.L., Xing Y., Ascherio A. Polymorphisms in vitamin D metabolism related genes and risk of multiple sclerosis. Mult. Scler. 2010, 16:133-138.
164. Sly L.M., Lopez M., Nauseef W.M., Reiner N.E. 1alpha, 25-Dihydroxyvitamin D3-induced monocyte antimycobacterial activity is regulated by phosphatidylinositol 3-kinase and mediated by the NADPH-dependent phagocyte oxidase. J. Biol. Chem. 2001, 276:35482-35493.
165. Smolders J., Damoiseaux J., Menheere P., Tervaert J.W., Hupperts R. Association study on two vitamin D receptor gene polymorphisms and vitamin D metabolites in multiple sclerosis. Ann. NY Acad. Sci. 2009, 1173:515-520.
166. Smolders J., Thewissen M., Peelen E., Menheere P., Cohen Tervaert J.W., Damoiseaux J., Hupperts R. Vitamin D status is positively correlated with regulatory T cell function in patients with multiple sclerosis. PLoS ONE 2009, 4:e6635.
167. Solomon A.J., Whitham R.H. Multiple sclerosis and vitamin D: A review and recommendations. Curr. Neurol. Neurosci. Rep. 2010, 10:389-396.
168. Sorensen O., Cowland J.B., Askaa J., Borregaard N. An ELISA for hCAP-18, the cathelicidin present in human neutrophils and plasma. J. Immunol. Methods 1997, 206:53-59.
169. Sorensen O.E., Follin P., Johnsen A.H., Calafat J., Tjabringa G.S., Hiemstra P.S., Borregaard N. Human cathelicidin, hCAP-18, is processed to the antimicrobial peptide LL-37 by extracellular cleavage with proteinase 3. Blood 2001, 97:3951-3959.
170. Spach K.M., Hayes C.E. Vitamin D3 confers protection from autoimmune encephalomyelitis only in female mice. J. Immunol. 2005, 175:4119-4126.
171. Spach K.M., Pedersen L.B., Nashold F.E., Kayo T., Yandell B.S., Prolla T.A., Hayes C.E. Gene expression analysis suggests that 1,25-dihydroxyvitamin D3 reverses experimental autoimmune encephalomyelitis by stimulating inflammatory cell apoptosis. Physiol. Genomics 2004, 18:141-151.
172. Spach K.M., Nashold F.E., Dittel B.N., Hayes C.E. IL-10 signaling is essential for 1,25-dihydroxyvitamin D3-mediated inhibition of experimental autoimmune encephalomyelitis. J. Immunol. 2006, 177:6030-6037.
173. Stoffels K., Overbergh L., Giulietti A., Verlinden L., Bouillon R., Mathieu C. Immune regulation of 25-hydroxyvitamin-D3-1alpha-hydroxylase in human monocytes. J. Bone Miner. Res. 2006, 21:37-47.
174. Strober W., Murray P.J., Kitani A., Watanabe T. Signalling pathways and molecular interactions of NOD1 and NOD2. Nat. Rev. Immunol. 2006, 6:9-20.
175. Sundqvist E., Baarnhielm M., Alfredsson L., Hillert J., Olsson T., Kockum I. Confirmation of association between multiple sclerosis and CYP27B1. Eur. J. Hum. Genet. 2010, 18:1349-1352.
176. Tajouri L., Ovcaric M., Curtain R., Johnson M.P., Griffiths L.R., Csurhes P., Pender M.P., Lea R.A. Variation in the vitamin D receptor gene is associated with multiple sclerosis in an Australian population. J. Neurogenet. 2005, 19:25-38.
177. Takahashi K., Nakayama Y., Horiuchi H., Ohta T., Komoriya K., Ohmori H., Kamimura T. Human neutrophils express messenger RNA of vitamin D receptor and respond to 1alpha, 25-dihydroxyvitamin D3. Immunopharmacol. Immunotoxicol. 2002, 24:335-347.
178. Talat N., Perry S., Parsonnet J., Dawood G., Hussain R. Vitamin D deficiency and tuberculosis progression. Emerg. Infect. Dis. 2010, 16:853-855.
179. Tang H.L., Cyster J.G. Chemokine up-regulation and activated T cell attraction by maturing dendritic cells. Science 1999, 284:819-822.
180. Tang J., Zhou R., Luger D., Zhu W., Silver P.B., Grajewski R.S., Su S.B., Chan C.C., Adorini L., Caspi R.R. Calcitriol suppresses antiretinal autoimmunity through inhibitory effects on the Th17 effector response. J. Immunol. 2009, 182:4624-4632.
181. Thoma-Uszynski S., Stenger S., Takeuchi O., Ochoa M.T., Engele M., Sieling P.A., Barnes P.F., Rollinghoff M., Bolcskei P.L., Wagner M., Akira S., Norgard M.V., et al. Induction of direct antimicrobial activity through mammalian toll-like receptors. Science 2001, 291:1544-1547.
182. Townsend K., Evans K.N., Campbell M.J., Colston K.W., Adams J.S., Hewison M. Biological actions of extra-renal 25-hydroxyvitamin D-1alpha-hydroxylase and implications for chemoprevention and treatment. J. Steroid Biochem. Mol. Biol. 2005, 97:103-109.
183. Vagianos K., Bector S., McConnell J., Bernstein C.N. Nutrition assessment of patients with inflammatory bowel disease. JPEN J. Parenter. Enteral Nutr. 2007, 31:311-319.
184. Veldman C.M., Cantorna M.T., DeLuca H.F. Expression of 1,25-dihydroxyvitamin D(3) receptor in the immune system. Arch. Biochem. Biophys. 2000, 374:334-338.
185. Waldmann T.A. The biology of interleukin-2 and interleukin-15: Implications for cancer therapy and vaccine design. Nat. Rev. Immunol. 2006, 6:595-601.
186. Wang T.T., Nestel F.P., Bourdeau V., Nagai Y., Wang Q., Liao J., Tavera-Mendoza L., Lin R., Hanrahan J.W., Mader S., White J.H. Cutting edge: 1,25-dihydroxyvitamin D3 is a direct inducer of antimicrobial peptide gene expression. J. Immunol. 2004, 173:2909-2912.
187. Wang T.T., Dabbas B., Laperriere D., Bitton A.J., Soualhine H., Tavera-Mendoza L.E., Dionne S., Servant M.J., Bitton A., Seidman E.G., Mader S., Behr M.A., et al. Direct and indirect induction by 1,25-dihydroxyvitamin D3 of the NOD2/CARD15-beta defensin 2 innate immune pathway defective in Crohn@apos;s disease. J. Biol. Chem. 2009, 285:2227-2231.
188. Wejse C., Olesen R., Rabna P., Kaestel P., Gustafson P., Aaby P., Andersen P.L., Glerup H., Sodemann M. Serum 25-hydroxyvitamin D in a West African population of tuberculosis patients and unmatched healthy controls. Am. J. Clin. Nutr. 2007, 86:1376-1383.
189. Wejse C., Gomes V.F., Rabna P., Gustafson P., Aaby P., Lisse I.M., Andersen P.L., Glerup H., Sodemann M. Vitamin D as supplementary treatment for tuberculosis: A double-blind, randomized, placebo-controlled trial. Am. J. Respir. Crit. Care Med. 2009, 179:843-850.
190. Westwood S.A., Seaman P.J., O Brien C., Thorogood L.J. The phenotypic frequencies of group specific component and alpha-2-HS-glycoprotein in three ethnic groups. The use of these proteins as racial markers in forensic biology. Forensic Sci. Int. 1987, 35:197-207.
191. White P., Cooke N. The multifunctional properties and characteristics of vitamin D-binding protein. Trends Endocrinol. Metab. 2000, 11:320-327.
192. Wu S., Ren S., Nguyen L., Adams J.S., Hewison M. Splice variants of the CYP27b1 gene and the regulation of 1,25-dihydroxyvitamin D3 production. Endocrinology 2007, 148:3410-3418.
193. Yang C.S., Shin D.M., Kim K.H., Lee Z.W., Lee C.H., Park S.G., Bae Y.S., Jo E.K. NADPH oxidase 2 interaction with TLR2 is required for efficient innate immune responses to mycobacteria via cathelicidin expression. J. Immunol. 2009, 182:3696-3705.
194. Yim S., Dhawan P., Ragunath C., Christakos S., Diamond G. Induction of cathelicidin in normal and CF bronchial epithelial cells by 1,25-dihydroxyvitamin D(3). J. Cyst. Fibros. 2007, 6:403-410.
195. Yu X.P., Mocharla H., Hustmyer F.G., Manolagas S.C. Vitamin D receptor expression in human lymphocytes. Signal requirements and characterization by western blots and DNA sequencing. J. Biol. Chem. 1991, 266:7588-7595.
196. Yu S., Bruce D., Froicu M., Weaver V., Cantorna M.T. Failure of T cell homing, reduced CD4/CD8alphaalpha intraepithelial lymphocytes, and inflammation in the gut of vitamin D receptor KO mice. Proc. Natl. Acad. Sci. USA 2008, 105:20834-20839.
197. Yuan J.Y., Freemont A.J., Mawer E.B., Hayes M.E. Regulation of 1 alpha, 25-dihydroxyvitamin D3 synthesis in macrophages from arthritic joints by phorbol ester, dibutyryl-cAMP and calcium ionophore (A23187). FEBS Lett. 1992, 311:71-74.
198. Yuk J.M., Shin D.M., Lee H.M., Yang C.S., Jin H.S., Kim K.K., Lee Z.W., Lee S.H., Kim J.M., Jo E.K. Vitamin D3 induces autophagy in human monocytes/macrophages via cathelicidin. Cell Host Microbe 2009, 6:231-243.
199. Zehnder D., Bland R., Williams M.C., McNinch R.W., Howie A.J., Stewart P.M., Hewison M. Extrarenal expression of 25-hydroxyvitamin d(3)-1 alpha-hydroxylase. J. Clin. Endocrinol. Metab. 2001, 86:888-894.
200. Zehnder D., Evans K.N., Kilby M.D., Bulmer J.N., Innes B.A., Stewart P.M., Hewison M. The ontogeny of 25-hydroxyvitamin D(3) 1alpha-hydroxylase expression in human placenta and decidua. Am. J. Pathol. 2002, 161:105-114.